ProShare Advisors’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-550
| Closed | -$20K | – | 2005 |
|
|
2022
Q1 | $20K | Sell |
550
-133
| -19% | -$4.84K | ﹤0.01% | 2174 |
|
|
2021
Q4 | $67K | Buy |
683
+4
| +0.6% | +$392 | ﹤0.01% | 2250 |
|
|
2021
Q3 | $98K | Sell |
679
-158
| -19% | -$22.8K | ﹤0.01% | 1919 |
|
|
2021
Q2 | $155K | Buy |
837
+116
| +16% | +$21.5K | ﹤0.01% | 2209 |
|
|
2021
Q1 | $177K | Buy |
721
+41
| +6% | +$10.1K | ﹤0.01% | 2071 |
|
|
2020
Q4 | $192K | Buy |
+680
| New | +$192K | ﹤0.01% | 1857 |
|
|
2017
Q4 | – | Sell |
-661
| Closed | -$188K | – | 1804 |
|
|
2017
Q3 | $188K | Buy |
661
+60
| +10% | +$17.1K | ﹤0.01% | 1291 |
|
|
2017
Q2 | $169K | Sell |
601
-24
| -4% | -$6.75K | ﹤0.01% | 1365 |
|
|
2017
Q1 | $209K | Sell |
625
-149
| -19% | -$49.8K | ﹤0.01% | 1432 |
|
|
2016
Q4 | $255K | Buy |
774
+231
| +43% | +$76.1K | ﹤0.01% | 1469 |
|
|
2016
Q3 | $145K | Sell |
543
-98
| -15% | -$26.2K | ﹤0.01% | 1386 |
|
|
2016
Q2 | $85K | Buy |
641
+9
| +1% | +$1.19K | ﹤0.01% | 1529 |
|
|
2016
Q1 | $112K | Sell |
632
-60
| -9% | -$10.6K | ﹤0.01% | 1506 |
|
|
2015
Q4 | $173K | Buy |
+692
| New | +$173K | ﹤0.01% | 1572 |
|